Buy or sell Sana Biotechnology stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Sana Biotechnology Stock

Sana Biotechnology focuses on creating and delivering engineered cells as medicine for patients.

About Sana Biotechnology Stock

Sana Biotechnology focuses on creating and delivering engineered cells as medicine for patients. Recent scientific advances make it possible to reprogram cells in the body or replace damaged cells and tissues, creating a new class of medicines to treat a broad array of diseases. The company is a team of scientists, clinicians and biotechnology veterans focused on creating an enduring company that makes meaningful medicines and will change the approach in treating diseases.

Management

Chief Business Officer

Christian Hordo

Chief Financial Officer

Nate Hardy

Chief Scientific Officer

Chad Cowan

President and Chief Executive Officer

Steve Harr

Chief Technology Officer

Andy May

General Counsel

James MacDonald

Chief Development Officer and Head of Portfolio Strategy

Sunil Agarwal

Chief People Officer

Robin Andrulevich

Other Companies

Learn More

Alector

Therapeutics for neurodegenerative disorders

Corporate credit card

Johnson & Johnson engages in the research and development, manufacture and sale of a range of products in the healthcare field.

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Sana Biotechnology or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Trending Companies

Join 90K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Why EquityZen?

EquityZen helps investors to access private companies and their employees to sell shares.

Investment opportunities posted on this website are "private placements" of securities that are not publicly traded, are subject to holding period requirements, and are intended for investors who do not need a liquid investment. Investing in private companies may be considered highly speculative and involves a high degree of risk, including the risk of substantial loss of investment. Investors must be able to afford the loss of their entire investment. See our Risk Factors for a more detailed explanation of the risks involved by investing through EquityZen’s platform.

EquityZen Securities LLC (“EquityZen Securities”) is a subsidiary of EquityZen Inc. EquityZen Securities is a broker/dealer registered with the Securities Exchange Commission and is a FINRA/SIPC member firm.

Equity securities are offered through EquityZen Securities. Check the background of this firm on FINRA’s BrokerCheck.

EquityZen.com is a website operated by EquityZen Inc. ("EquityZen"). By accessing this site and any pages thereof, you agree to be bound by our Terms of Use.
EquityZen and logo are trademarks of EquityZen Inc. Other trademarks are property of their respective owners.
© 2020 EquityZen Inc. All rights reserved.